{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:06:27Z","timestamp":1780463187535,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T00:00:00Z","timestamp":1442448000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1116-4","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:38:34Z","timestamp":1444264714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission"],"prefix":"10.1186","volume":"15","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,17]]},"reference":[{"key":"1116_CR1","unstructured":"World Health Organization. Global Polio Eradication Initiative: Polio Eradication and Endgame Strategic Plan (2013\u20132018). Geneva, 2013; Report No.:\u00a0\u200bWHO\/POLIO\/13.02."},{"issue":"Suppl 1","key":"1116_CR2","doi-asserted-by":"publisher","first-page":"S475","DOI":"10.1093\/infdis\/jit845","volume":"210","author":"KM Thompson","year":"2014","unstructured":"Thompson KM, Duintjer Tebbens RJ. Modeling the dynamics of oral poliovirus vaccine cessation. J Infect Dis. 2014;210 Suppl 1:S475\u201384.","journal-title":"J Infect Dis"},{"issue":"S1","key":"1116_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/infdis\/jit838","volume":"210","author":"RJ Duintjer Tebbens","year":"2014","unstructured":"Duintjer Tebbens RJ, Thompson KM. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation. J Infect Dis. 2014;210(S1):485\u201397.","journal-title":"J Infect Dis"},{"issue":"6","key":"1116_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130123","volume":"10","author":"RJ Duintjer Tebbens","year":"2015","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Wassilak SGF, Cochi SL, Thompson KM. Combinations of quality and frequency of immunization activities to stop and prevent poliovirus transmission in the high-risk area of northwest Nigeria. PLoS One. 2015;10(6), e0130123.","journal-title":"PLoS One"},{"issue":"S1","key":"1116_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/infdis\/jit844","volume":"210","author":"DA Kalkowska","year":"2014","unstructured":"Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India. J Infect Dis. 2014;210(S1):398\u2013411.","journal-title":"J Infect Dis"},{"issue":"S1","key":"1116_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/infdis\/jit834","volume":"210","author":"DA Kalkowska","year":"2014","unstructured":"Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria. J Infect Dis. 2014;210(S1):412\u201323.","journal-title":"J Infect Dis"},{"key":"1116_CR7","doi-asserted-by":"crossref","unstructured":"Jafari H, Deshpande JM, Sutter RW, Bahl S, Verma H, Ahmad M, et al. Polio eradication. Efficacy of inactivated poliovirus vaccine in India. Science. 2014;345(6199):922\u20135.","DOI":"10.1126\/science.1255006"},{"key":"1116_CR8","doi-asserted-by":"crossref","unstructured":"John J, Giri S, Karthikeyan AS, Iturriza-Gomara M, Muliyil J, Abraham A, et al. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial. Lancet. 2014;384(9953):1505\u201312.","DOI":"10.1016\/S0140-6736(14)60934-X"},{"issue":"4","key":"1116_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/risa.12044","volume":"23","author":"RJ Duintjer Tebbens","year":"2013","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Kalkowska DA, Wassilak SG, Cochi SL, Thompson KM. Characterizing poliovirus transmission and evolution: Insights from modeling experiences with wild and vaccine-related polioviruses. Risk Anal. 2013;23(4):703\u201349.","journal-title":"Risk Anal"},{"key":"1116_CR10","doi-asserted-by":"crossref","unstructured":"Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SGF, et al. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis. 2015;211(11):1800\u201312.","DOI":"10.1093\/infdis\/jiu674"},{"key":"1116_CR11","doi-asserted-by":"crossref","unstructured":"Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, Heymann DL, et al. New strategies for the elimination of polio from India. Science. 2006;314(5802):1150\u20133.","DOI":"10.1126\/science.1130388"},{"key":"1116_CR12","doi-asserted-by":"crossref","unstructured":"Upfill-Brown AM, Lyons HM, Pate MA, Shuaib F, Baig S, Hu H, et al. Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria. BMC Med. 2014;12:92.","DOI":"10.1186\/1741-7015-12-92"},{"key":"1116_CR13","doi-asserted-by":"crossref","unstructured":"Grassly NC, Wenger J, Durrani S, Bahl S, Deshpande JM, Sutter RW, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case\u2013control study. Lancet. 2007;369(9570):1356\u201362.","DOI":"10.1016\/S0140-6736(07)60531-5"},{"issue":"4","key":"1116_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1539-6924.2012.01891.x","volume":"33","author":"KM Thompson","year":"2013","unstructured":"Thompson KM, Pallansch MA, Duintjer Tebbens RJ, Wassilak SGF, Cochi SL. Modeling population immunity to support efforts to end the transmission of live polioviruses. Risk Anal. 2013;33(4):647\u201363.","journal-title":"Risk Anal"},{"key":"1116_CR15","doi-asserted-by":"crossref","unstructured":"Thompson KM, Kalkowska DA, Duintjer Tebbens RJ. Managing population immunity to reduce or eliminate the risks of circulation following the importation of live polioviruses. Vaccine. 2015;33(3):1568\u201377.","DOI":"10.1016\/j.vaccine.2015.02.013"},{"key":"1116_CR16","doi-asserted-by":"crossref","unstructured":"Thompson KM, Kalkowska DA, Duintjer Tebbens RJ. Managing population immunity to reduce or eliminate the risks of circulation following the importation of live polioviruses. Vaccine. 2015;33(3):1568\u201377.","DOI":"10.1016\/j.vaccine.2015.02.013"},{"key":"1116_CR17","doi-asserted-by":"crossref","unstructured":"Duintjer Tebbens RJ, Kalkowska DA, Wassilak SGF, Pallansch MA, Cochi SL, Thompson KM. The potential impact of expanding target age groups for polio immunization campaigns. BMC Infect Dis. 2014;14:45.","DOI":"10.1186\/1471-2334-14-45"},{"issue":"12","key":"1116_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113538","volume":"9","author":"BG Wagner","year":"2014","unstructured":"Wagner BG, Behrend MR, Klein DJ, Upfill-Brown AM, Eckhoff PA, Hu H. Quantifying the impact of expanded age group campaigns for polio eradication. PLoS One. 2014;9(12), e113538.","journal-title":"PLoS One"},{"issue":"66","key":"1116_CR19","first-page":"1","volume":"15","author":"DA Kalkowska","year":"2015","unstructured":"Kalkowska DA, Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SGF, Thompson KM. Modeling undetected live poliovirus circulation after apparent interruption of transmission: Implications for surveillance and vaccination. BMC Infect Dis. 2015;15(66):1.","journal-title":"BMC Infect Dis"},{"key":"1116_CR20","doi-asserted-by":"publisher","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Wassalik SGF, Cochi SL, Thompson KM: An economic analysis of poliovirus risk management policy options for 2013\u20132052. doi: 10.1186\/s12879-015-1112-8 BMC Inf Dis 2015","DOI":"10.1186\/s12879-015-1112-8"},{"issue":"4","key":"1116_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/risa.12019","volume":"33","author":"KM Thompson","year":"2013","unstructured":"Thompson KM, Pallansch MA, Duintjer Tebbens RJ, Wassilak SG, Kim J-H, Cochi SL. Pre-eradication vaccine policy options for poliovirus infection and disease control. Risk Anal. 2013;33(4):516\u201343.","journal-title":"Risk Anal"},{"key":"1116_CR22","doi-asserted-by":"crossref","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Kim J-H, Burns CC, Kew OM, Oberste MS, et al. Review: Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). Risk Anal. 2013;23(4):680\u2013702.","DOI":"10.1111\/risa.12022"},{"key":"1116_CR23","volume-title":"Nigeria Demographic and Health Survey 2013","author":"National Population Commission Nigeria and ICF International","year":"2014","unstructured":"National Population Commission Nigeria and ICF International. Nigeria Demographic and Health Survey 2013. Abuja: NPC and ICF International; 2014."},{"key":"1116_CR24","unstructured":"World Health Organization: WHO\/UNICEF estimated coverage time series. 2014. http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragepol3.html . Accessed May 29\u00a02014."},{"key":"1116_CR25","doi-asserted-by":"crossref","unstructured":"Sutter RW, John TJ, Jain H, Agarkhedkar S, Ramanan PV, Verma H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet. 2010;376(9753):1682\u20138.","DOI":"10.1016\/S0140-6736(10)61230-5"},{"key":"1116_CR26","doi-asserted-by":"crossref","unstructured":"Est\u00edvariz CF, Anand A, Gary Jr HE, Rahman M, Islam J, Bari TI, et al. Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial. Lancet Infect Dis. 2015;15(8):898\u2013904.","DOI":"10.1016\/S1473-3099(15)00094-8"},{"key":"1116_CR27","doi-asserted-by":"crossref","unstructured":"Grassly NC, Jafari H, Bahl S, Durrani S, Wenger J, Sutter RW, et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis. 2009;200(5):794\u2013801.","DOI":"10.1086\/605330"},{"key":"1116_CR28","doi-asserted-by":"crossref","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, et al. Expert review on poliovirus immunity and transmission. Risk Anal. 2013;33(4):544\u2013605.","DOI":"10.1111\/j.1539-6924.2012.01864.x"},{"issue":"5","key":"1116_CR29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/infdis\/171.5.1097","volume":"171","author":"World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine","year":"1995","unstructured":"World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J Infect Dis. 1995;171(5):1097\u2013106.","journal-title":"J Infect Dis"},{"key":"1116_CR30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","volume":"13","author":"PA Patriarca","year":"1991","unstructured":"Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13:926\u201339.","journal-title":"Rev Infect Dis"},{"key":"1116_CR31","doi-asserted-by":"crossref","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, et al. Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs. Risk Anal. 2013;33(4):606\u201346.","DOI":"10.1111\/risa.12031"},{"issue":"11","key":"1116_CR32","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/aje\/kws378","volume":"177","author":"BT Mayer","year":"2013","unstructured":"Mayer BT, Eisenberg JN, Henry CJ, Gomes MG, Ionides EL, Koopman JS. Successes and shortcomings of polio eradication: a transmission modeling analysis. Am J Epidemiol. 2013;177(11):1236\u201345.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1116_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002599","volume":"8","author":"TR Hird","year":"2012","unstructured":"Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4), e1002599.","journal-title":"PLoS Pathog"},{"key":"1116_CR34","unstructured":"Global Polio Eradication Initiative-circulating vaccine-derived poliovirus cases 2000\u20132015. 2015.\u00a0 http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Circulatingvaccinederivedpoliovirus.aspx . Accessed July 28 2015."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1116-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T09:10:12Z","timestamp":1567242612000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1116-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,17]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1116-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,17]]},"article-number":"376"}}